If you've ever sat through a marketing review where someone proudly announces "50,000 impressions this month," you already know the problem with pharma reporting. Impressions don't write prescriptions. Clicks don't either. Most of the metrics dashboards default to were built for e-commerce, where a click can end in a sale within minutes. Pharma doesn't work that way, and pretending it does just leaves brand teams staring at numbers that feel good but mean very little.
So what should you actually be watching?
First, stop worshipping vanity numbers
Impressions and page views are fine as background context, but they shouldn't be the headline metric in any report. You can hit five-figure impression counts and still not reach a single doctor who matters. If a number makes a slide look impressive but doesn't tell you who saw it, be skeptical of it.
Look at how HCPs actually engage, not just that they clicked
A click is the beginning of the story, not the end of it. What matters more is whether a doctor spent real time with the content, and whether they came back for a second look. A rep detailing a new drug once is one thing — a doctor pulling up the same dosing PDF three separate times is a completely different signal. Also worth watching: which formats HCPs gravitate toward. Some will sit through a full video; others skim a PDF for ten seconds and bounce. That tells you where to put your production effort next time.
Don't ignore the funnel just because it's messy
Pharma will never have the clean "click → purchase" tracking that retail has, and that's fine — you work with what's available. Things worth tracking here: how often a digital touchpoint actually leads to a medical rep follow-up, whether sample or detailing requests spike after a campaign, and — where you can actually get this data — whether there's any traceable lift in prescriptions. That last one is hard to pin down cleanly, but it's the number that actually matters to the people funding the campaign.
Use proxies where direct tracking isn't possible
Since you can't always draw a straight line to prescribing behavior, lean on the next best thing: form fills, CME or webinar completions, and post-campaign logins to a portal or WhatsApp channel. None of these alone prove much, but tracked consistently over months, they start to show real patterns worth acting on.
Judge spend by outcome, not clicks
Cost-per-click is a hangover from industries that don't apply here. What's actually worth calculating is cost per HCP genuinely engaged, and cost per lead that a rep or medical team has actually verified as real interest. A campaign that looks cheap on a per-click basis but produces zero verified engagement isn't actually cheap — it's just quiet.
Different channels need different judgment calls
Google and Meta campaigns should be evaluated on whether they're reaching the right audience — hospitals, clinics, the correct specialties — not just how many people clicked. LinkedIn is worth judging almost entirely on job-title and seniority match among the people who engaged. A LinkedIn campaign with a great CTR but a pile of engagement from students and unrelated professionals hasn't actually done its job.
Where this leaves you
None of this is about chasing bigger numbers. It's about asking a much simpler question every time you look at a report: did this actually reach a doctor, and did that doctor do anything meaningful with it? Everything else is decoration.